Advanced Extramammary Paget’s Disease of the Groin, Penis, and Scrotum

by Isrow, Derek, Oregel, Karlos Z, Cortes, Javier, Gomez, Henry, Milikowski, Clara, Feun, Lynn, Silva, Orlando
Published 2014

A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma

by Hamid, Omid, Schmidt, Henrik, Nissan, Aviram, Ridolfi, Laura, Aamdal, Steinar, Hansson, Johan, Guida, Michele, Hyams, David M, Gómez, Henry, Bastholt, Lars, Chasalow, Scott D, Berman, David
Published 2011

A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study):...

by Baselga, José, Costa, Frederico, Gomez, Henry, Hudis, Clifford A, Rapoport, Bernardo, Roche, Henri, Schwartzberg, Lee S, Petrenciuc, Oana, Shan, Minghua, Gradishar, William J
Published 2013

Cancer clinical research in Latin America: current situation and opportunities. Expert opinion from the first ESMO workshop on clinical trials, Lima, 2015

by Rolfo, Christian, Caglevic, Christian, Bretel, Denisse, Hong, David, Raez, Luis E, Cardona, Andres F, Oton, Ana B, Gomez, Henry, Dafni, Urania, Vallejos, Carlos, Zielinski, Christoph
Published 2016

A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer

by Cristofanilli, Massimo, Johnston, Stephen R. D., Manikhas, Alexey, Gomez, Henry L., Gladkov, Oleg, Shao, Zhimin, Safina, Sufia, Blackwell, Kimberly L., Alvarez, Ricardo H., Rubin, Stephen D., Ranganathan, Sulabha, Redhu, Suman, Trudeau, Maureen E.
Published 2012

Repeated observation of immune gene sets enrichment in women with non-small cell lung cancer

by Araujo, Jhajaira M., Prado, Alexandra, Cardenas, Nadezhda K., Zaharia, Mayer, Dyer, Richard, Doimi, Franco, Bravo, Leny, Pinillos, Luis, Morante, Zaida, Aguilar, Alfredo, Mas, Luis A., Gomez, Henry L., Vallejos, Carlos S., Rolfo, Christian, Pinto, Joseph A.
Published 2016

PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors

by Lehmann, Brian D, Bauer, Joshua A, Schafer, Johanna M, Pendleton, Christopher S, Tang, Luojia, Johnson, Kimberly C, Chen, Xi, Balko, Justin M, Gómez, Henry, Arteaga, Carlos L, Mills, Gordon B, Sanders, Melinda E, Pietenpol, Jennifer A
Published 2014

Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy

by Castaneda, Carlos A, Mittendorf, Elizabeth, Casavilca, Sandro, Wu, Yun, Castillo, Miluska, Arboleda, Patricia, Nunez, Teresa, Guerra, Henry, Barrionuevo, Carlos, Dolores-Cerna, Ketty, Belmar-Lopez, Carolina, Abugattas, Julio, Calderon, Gabriela, De La Cruz, Miguel, Cotrina, Manuel, Dunstan, Jorge, Gomez, Henry L, Vidaurre, Tatiana
Published 2016